Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Phenotypic and Genetic Properties in Male Subjects Affected By Hypohidrotic Ectodermal Dysplasia (ECP-012)

NCT01629927 is registered in ClinicalTrials.gov with Edimer Pharmaceuticals as lead sponsor.

NCT NCT01629927
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01629927 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Phenotypic and Genetic Properties in Male Subjects Affected By Hypohidrotic Ectodermal Dysplasia (ECP-012)
Lead sponsor
Edimer Pharmaceuticals
Phase
Observational
Overall status
Completed
Start date
March 31, 2012
Completion date
June 30, 2012
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypohidrotic ectodermal dysplasia, x-linked hypohidrotic ectodermal dysplasia